Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties
Protein kinase A (PKA) activation has recently been reported to inhibit epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) ability, which is considered to be responsible for chemoresistance and tumor recurrence in patients. While current studies mainly focus on gene manipulation of t...
Saved in:
Main Authors: | Jun-Nian Zhou (Author), Tzu-Chen Rautio (Author), Chang Liu (Author), Xiao-Yu Xu (Author), Dong-Qing Wang (Author), Yong Guo (Author), John Eriksson (Author), Hongbo Zhang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protein Kinases and Their Inhibitors in Pluripotent Stem Cell Fate Regulation
by: Jungwoon Lee, et al.
Published: (2019) -
AMP-activated protein kinase promotes breast cancer stemness and drug resistance
by: Sai Balaji Andugulapati, et al.
Published: (2022) -
Menthol response and adaptation in nociceptive-like and nonnociceptive-like neurons: role of protein kinases
by: Sarria Ignacio, et al.
Published: (2010) -
Wound healing properties of the protein kinase A inhibitor and the mechanisms of their development
by: Gleb N. Zyuz`kov, et al.
Published: (2021) -
Protein kinase inhibitors for acute leukemia
by: Yuan Ling, et al.
Published: (2018)